Epizeal 133.5mg/58mg Tablet CR
By Epizeal
Rx
10 Tablet CR in a Strip

Composition
Sodium Valproate(133.5mg) + Valproic Acid(58mg)

Manufacturer - Amazeal Life Science Pvt Ltd
BLOCK GI- 52, GROUND FLOOR, 1831, RAJDANGA MAIN ROAD, P.O- EKTP, P.S- KASBA, KOLKATA Kolkata WB 700107 IN

Expires on or after
October, 2025

liver
When using Epizeal 133.5mg/58mg Tablet CR, it's important to be cautious if you have liver disease. Patients with liver issues may require adjustments to their dosage, so consulting your doctor before starting this medication is essential. It is not recommended to use Epizeal 133.5mg/58mg Tablet CR in cases of severe or active liver disease. If you have any liver concerns, make sure to seek advice from your healthcare provider to ensure the safe usage of this medicine.

kidney
Epizeal 133.5mg/58mg Tablet CR is likely safe in patients with kidney disease. Data suggests dose adjustment may not be necessary. Consult your doctor, especially if you have underlying kidney issues.

alcohol
Consuming alcohol with Epizeal 133.5mg/58mg Tablet CR is not safe.

driving
When using Epizeal 133.5mg/58mg Tablet CR, be cautious when driving. It may cause drowsiness, impact vision, or reduce alertness. Avoid driving if you experience these effects.

pregnancy
Epizeal 133.5mg/58mg Tablet CR is not safe to use during pregnancy. There is clear evidence of risk to the baby's development. In extreme cases, the doctor may prescribe it if benefits outweigh risks. Please consult your doctor before use.

breastfeeding
Epizeal 133.5mg/58mg Tablet CR is safe to use while breastfeeding. Studies show the drug does not pass into breastmilk in significant amounts and is not harmful to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹41
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024